Vanguard Group’s Faeth Therapeutics, Inc. Common Stock FTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $250K | Sell |
|
|||||
|
2025
Q1 | $231K | Sell |
|
|||||
|
2024
Q4 | $291K | Sell |
|
|||||
|
2024
Q3 | $370K | Hold |
|
|||||
|
2024
Q2 | $384K | Buy |
|
|||||
|
2024
Q1 | $603K | Buy |
|
|||||
|
2023
Q4 | $397K | Hold |
|
|||||
|
2023
Q3 | $459K | Hold |
|
|||||
|
2023
Q2 | $654K | Hold |
|
|||||
|
2023
Q1 | $860K | Hold |
|
|||||
|
2022
Q4 | $855K | Buy |
|
|||||
|
2022
Q3 | $889K | Sell |
|
|||||
|
2022
Q2 | $1.52M | Sell |
|
|||||
|
2022
Q1 | $1.75M | Buy |
|
|||||
|
2021
Q4 | $4.37M | Buy |
|
|||||
|
2021
Q3 | $7.86M | Buy |
|
|||||
|
2021
Q2 | $3.78M | Buy |
|
|||||
|
2021
Q1 | $4.72M | Buy |
|